SR

Sudheerkumar Ramachandran Nair

Active Director Director DIN 06411807
DIN 06411807 First appointment Nov 2012 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudheerkumar Ramachandran Nair

Data last updated:

Sudheerkumar Ramachandran Nair is a Director at Spiritus Pharmaceuticals Private Limited (since 2012). The company operates in Trading.

DIN 06411807
Primary Designation Director
Industry Trading
First Appointment 09 Nov 2012
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20122012Active

Board colleagues of Sudheerkumar Ramachandran Nair

NameDINCompanyDesignation
Suresh Kumar06889745Spiritus Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Spiritus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sudheerkumar Ramachandran Nair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudheerkumar Ramachandran Nair

Sudheerkumar Ramachandran Nair currently holds 1 directorship: Spiritus Pharmaceuticals Private Limited (Director, since 09 Nov 2012).

Sudheerkumar Ramachandran Nair was first appointed on 09 Nov 2012 as Director at Spiritus Pharmaceuticals Private Limited.

The current boards of Sudheerkumar Ramachandran Nair's companies include Suresh Kumar (Spiritus Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available